Editorial for an official journal of the American association of pharmaceutical scientists,AAPS Open

当前位置： X-MOL 学术 › AAPS Open › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Editorial for an official journal of the American association of pharmaceutical scientists
AAPS Open Pub Date : 2015-11-19 , DOI: 10.1186/s41120-015-0001-y
Christopher M. Riley

I am delighted and honored to have been selected as the first Editor-in-Chief of AAPS Open, an open-access journal devoted to the rapid publication of quality articles in the pharmaceutical sciences. The journal will be a global forum for the barrier-free publication of reports of original research, as well as other significant work that demonstrates applications of scientific concepts and techniques across the entire breadth of the field. Thus AAPS Open will provide an important outlet for members of AAPS sections and focus groups to publish papers of interest to their communities, as well as for scientists throughout the field.

All AAPS Open articles will be fully peer reviewed by scientists with extensive knowledge in the subject matter. The editorial team, consisting of the associate editors and myself, has been aligned with the sections of AAPS to ensure that all aspects of the pharmaceutical sciences are covered, including but not limited to pharmaceutical and biomedical analysis, quality control, quality assurance, pharmaceutical biotechnology, biopharmaceutics, clinical pharmacology, translational research, drug discovery and its interface with drug development, formulation design, manufacturing science and engineering, physical pharmacy, pharmacokinetics, pharmacodynamics, drug metabolism, and regulatory affairs.

I want to thank the following eight well-known pharmaceutical scientists for agreeing to join the AAPS Open editorial team as associate editors: Nagesh Bandi (Pfizer), Varsha Bhatt-Mehta (University of Michigan), Panos Constantinides (BioPharmaceutical & Drug Delivery Consulting), Nikoletta Fotaki (University of Bath), Jayne Hastedt (JPD Pharma), Tim Hickling (Pfizer), Jaime Marach (CUSTOpharm) and Jean Lee (BioQualQuan). We are in the process of assembling a noteworthy editorial board comprised of internationally recognized pharmaceutical scientists who will help guide the journal.

One of the obvious advantages of publishing in a completely open-access journal is the speed of publication. Given the ever-increasing pace of drug development, we hope that this advantage will encourage the publication of critical issues in drug development and stimulate lively discussions. AAPS Open will provide an opportunity for pharmaceutical scientists to share their experiences during the normal course of drug development as well as original research articles, reviews, opinions, commentaries, and industry best practices. We also encourage the submission of protocols of general interest and databases. The journal is open for submissions now. Membership in AAPS is not a requirement for publication in AAPS Open, and we look forward to receiving articles for consideration that will be of interest to everyone involved in the drug research and development.

Affiliations

Riley and Rabel Consulting Services, Maryville, MO, USA
Christopher M. Riley

Authors

Christopher M. RileyView author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher M. Riley.

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

Cite this article

Riley, C.M. Editorial for an official journal of the American association of pharmaceutical scientists. AAPS Open 1, 1 (2015). https://doi.org/10.1186/s41120-015-0001-y

Download citation

Received: 08 October 2015
Accepted: 08 October 2015
Published: 19 November 2015
DOI: https://doi.org/10.1186/s41120-015-0001-y

中文翻译：

美国药物科学家协会官方杂志的社论

我很高兴也很荣幸被评选为AAPS Open的第一位总编辑，AAPS Open是致力于药物科学中高质量文章快速发表的开放获取期刊。该杂志将是一个全球论坛，无障碍出版原始研究报告，以及其他重要成果，展示科学概念和技术在整个领域的应用。因此，AAPS公开赛将为AAPS部门和焦点小组的成员提供重要的出路，让他们发表对其社区以及整个领域的科学家感兴趣的论文。

所有具有AAPS开放性的文章都将由具有广泛主题知识的科学家进行全面的同行评审。由副编辑和我本人组成的编辑团队已与AAPS的各个部分保持一致，以确保涵盖药物科学的所有方面，包括但不限于药物和生物医学分析，质量控制，质量保证，药物生物技术，生物制药，临床药理学，转化研究，药物发现及其与药物开发，制剂设计，制造科学与工程，物理药学，药代动力学，药效学，药物代谢和监管事务的接口。

我要感谢以下八位著名的制药科学家同意加入APS开放编辑团队，担任副编辑：Nagesh Bandi（辉瑞公司），Varsha Bhatt-Mehta（密歇根大学），Panos Constantinides（生物制药和药物输送咨询公司），巴斯大学的Nikoletta Fotaki，JPD Pharma的Jayne Hastedt，辉瑞的Tim Hickling，CUSTOpharm的Jaime Marach和BioQualQuan的Jean Lee。我们正在组建一个由国际知名制药科学家组成的值得注意的编辑委员会，他们将为该杂志提供指导。

在完全开放获取的期刊上进行出版的明显优势之一是出版速度。鉴于药物开发的步伐不断提高，我们希望这种优势将鼓励药物开发中关键问题的发表并引起热烈的讨论。AAPS公开赛将为制药科学家提供一个在正常药物开发过程中分享他们的经验以及原创研究文章，评论，意见，评论和行业最佳实践的机会。我们还鼓励提交普遍感兴趣的协议和数据库。该期刊现已开放供提交。在AAPS Open中发布并不需要成为AAPS的成员， 我们期待收到与药物研发有关的所有人都感兴趣的文章。